WS #10427

15:38→16:02 UTC

From 499 msgs · 5 key-dev

AbbVie acquires Apogee Therapeutics for $135.11/share; Praxis Precision Medicines gets FDA Breakthrough Therapy designation for elsunersen.

Biotech M&A and drug approvals

AbbVie acquires Apogee Therapeutics for $135.11/share; Praxis Precision Medicines gets FDA Breakthrough Therapy designation for elsunersen.